Description
Sarafloxacin is a quinolone antibiotic drug, inhibiting the topoisomerase II ligase domain. It inhibits bacterial Topo II α (DNA gyrase, topoisomerase) and is effective against Mycobacterium tuberculosis.
Synonyms
Sarafloxacin HCl; A-56620; A 56620; A56620
IUPAC Name
6-fluoro-1-(4-fluorophenyl)-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;hydrochloride
Molecular Formula
C20H17F2N3O3.HCl
Canonical SMILES
C1CN(CCN1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=CC=C(C=C4)F)F.Cl
InChI
InChI=1S/C20H17F2N3O3.ClH/c21-12-1-3-13(4-2-12)25-11-15(20(27)28)19(26)14-9-16(22)18(10-17(14)25)24-7-5-23-6-8-24;/h1-4,9-11,23H,5-8H2,(H,27,28);1H
InChIKey
KNWODGJQLCISLC-UHFFFAOYSA-N
Boiling Point
621.4°C at 760 mmHg
Melting Point
>240°C (dec.)
Solubility
Soluble in DMSO
Appearance
Pale Yellow Solid